Mitochondrial 3-hydroxymethylglutaryl-CoA synthase-2 (HMGCS2) deficiency: A rare case with bicytopenia and coagulopathy

Dalia El-Sayed, Hanaa El-Karaksy, Yasser Wali*, Ilham Youssry

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Mitochondrial 3-hydroxymethylglutaryl-CoA synthase-2 (HMGCS2) is the main enzyme involved in ketogenesis. It is an essential enzyme for the catalysis of β-oxidation-derived-Acetyl-CoA and acetoacetyl Co-A to produce β-hydroxy-β-methylglutaryl-CoA (HMG-CoA) and free coenzyme A. The deficiency of this enzyme (3-hydoxy-3-methylglutaryl-CoA synthase) is a very rare metabolic disorder with limited cases described in the literature. The manifestations of this disease include hypoketotic hypoglycaemia, metabolic acidosis, lethargy, hepatomegaly with fatty liver and encephalopathy. We report a middle childhood male who presented with hepatosplenomegaly, lymphadenopathy and bicytopenia. The case was diagnosed by the whole exome sequencing which revealed a homozygous missense variant of uncertain significance in HMGCS2 gene.

Original languageEnglish
Article numbere257011
JournalBMJ Case Reports
Volume16
Issue number11
DOIs
Publication statusPublished - Nov 6 2023

Keywords

  • Haematology (incl blood transfusion)
  • Metabolic disorders
  • Blood Coagulation Disorders
  • Ketone Bodies/metabolism
  • Mitochondria/metabolism
  • Humans
  • Hydroxymethylglutaryl-CoA Synthase/genetics
  • Male
  • Mutation, Missense
  • Acidosis
  • Child

ASJC Scopus subject areas

  • General Medicine

Cite this